Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol

Antonio Molino, Giovanna Calabrese, Mauro Maniscalco
  • Patient Preference and Adherence, June 2018, Dove Medical Press
  • DOI: 10.2147/ppa.s152179

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/ppa.s152179

The following have contributed to this page: Dr Mauro Maniscalco